HZ-Q1060

N/A

Report date: 2023/03/02 14:09:22
NME

Base Information

Drug NameHZ-Q1060
Drug Alias NameHZ-Q1060
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK degraders
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHeaZen Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeaZen Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A